NHS England Offers ‘Improved’ Orkambi Deal, But Vertex Lukewarm

 
• By Ian Schofield
CysticFibrosis
Talks are continuing on access to Vertex's CF drug Orkambi • Source: Shutterstock

More from Health Technology Assessment

More from Market Access